wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26849264-1A62FF32-9330-4A79-B1E5-164A628E60B7
Q26849264-1A62FF32-9330-4A79-B1E5-164A628E60B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26849264-1A62FF32-9330-4A79-B1E5-164A628E60B7
Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
P2860
Q26849264-1A62FF32-9330-4A79-B1E5-164A628E60B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26849264-1A62FF32-9330-4A79-B1E5-164A628E60B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc35cbce550af685fb348177459729a6c9d27251
P2860
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer.